The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 31, Pages -
Publisher
Proceedings of the National Academy of Sciences
Online
2022-07-16
DOI
10.1073/pnas.2204336119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore
- (2022) Chin Shern Lau et al. Vaccines
- Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
- (2022) Ariel Israel et al. Vaccines
- SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India
- (2022) Sumit Malhotra et al. JAMA Network Open
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
- (2022) Gili Regev-Yochay et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
- (2022) Jinni Chen et al. Frontiers in Immunology
- Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
- (2022) Watsamon Jantarabenjakul et al. Vaccines
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
- (2021) Charlotte Manisty et al. EBioMedicine
- A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
- (2021) Thomas Hale et al. Nature Human Behaviour
- Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for up to 10 Months after Infection
- (2021) Julien Favresse et al. Microorganisms
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
- (2021) Ross J. Harris et al. JOURNAL OF INFECTION
- COVID-19 dynamics after a national immunization program in Israel
- (2021) Hagai Rossman et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses
- (2021) F. Javier Ibarrondo et al. ACS Nano
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
- (2021) Helen Parry et al. Immunity & Ageing
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
- (2021) Benjamin Israelow et al. Science Immunology
- Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
- (2021) Emanuele Amodio et al. Vaccines
- mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
- (2021) Dorit Fabricius et al. Vaccines
- Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
- (2021) David J Bean et al. CLINICAL INFECTIOUS DISEASES
- Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
- (2021) Vivek Naranbhai et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
- (2021) Carolina Lucas et al. NATURE
- Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
- (2021) Alice Cho et al. NATURE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
- (2021) Jean-Louis Bayart et al. Vaccines
- Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines
- (2021) José G. Montoya et al. Microbiology Spectrum
- The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
- (2021) Jeffrey P Townsend et al. Lancet Microbe
- IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
- (2020) Bui Quang Minh et al. MOLECULAR BIOLOGY AND EVOLUTION
- Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic
- (2020) Maciej F. Boni et al. Nature Microbiology
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms
- (2018) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- Rphylopars: fast multivariate phylogenetic comparative methods for missing data and within-species variation
- (2016) Eric W. Goolsby et al. Methods in Ecology and Evolution
- Fast Dating Using Least-Squares Criteria and Algorithms
- (2015) Thu-Hien To et al. SYSTEMATIC BIOLOGY
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
- (2014) Alexandros Stamatakis BIOINFORMATICS
- A Linear-Time Algorithm for Gaussian and Non-Gaussian Trait Evolution Models
- (2014) Lam si Tung Ho et al. SYSTEMATIC BIOLOGY
- Estimating divergence times in large molecular phylogenies
- (2012) K. Tamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now